Eurobarometer, Special. Eurobarometer 72.3. Sport and Physical Activity, Wave EB80 2. Brussels: Directorate General Education and Culture; 2010.
Facts about physical activity [Internet]. 2014. Available from: https://www.cdc.gov/physicalactivity/data/facts.htm. Accessed 28 Feb 2017.
Facts on Health & Fitness Clubs [Internet]. 2016. https://www.statista.com/topics/1141/health-and-fitness-clubs/. Accessed 28 Feb 2017.
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet (London, England). 2012;380(9838):219–29.
Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in the health and fitness community: a regional study. European journal of internal medicine. 2006;17(7):479–84.
Sagoe D, McVeigh J, Bjornebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015;10:12.
Sjoqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet (London, England). 2008;371(9627):1872–82.
Dodge T, Hoagland MF. The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug Alcohol Depend. 2011;114(2–3):100–9.
Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: diagnostic challenges, patterns of use and health. Current opinion in psychiatry. 2014;27(4):269–75.
Midanik LT, Tam TW, Weisner C. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007;90(1):72–80.
Backhouse S, Collins C, Defoort Y, McNamee M, Parkinson A, Sauer M, et al. Study on doping prevention: a map of legal, regulatory and prevention practice provisions in EU 28. 2014.
Denham BE. Association between narcotic use and anabolic-androgenic steroid use among American adolescents. Subst Use Misuse. 2009;44(14):2043–61.
Nyberg F, Hallberg M. Interactions between opioids and anabolic androgenic steroids: implications for the development of addictive behavior. Int Rev Neurobiol. 2012;102:189–206.
Kanayama G, Pope HG, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003;71(1):77–86.
Laure P, Lecerf T, Friser A, Binsinger C. Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med. 2004;25(2):133–8.
Moore MJ, Werch CE. Sport and physical activity participation and substance use among adolescents. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2005;36(6):486–93.
Thevis M, Sauer M, Geyer H, Sigmund G, Mareck U, Schanzer W. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry. J Sports Sci. 2008;26(10):1059–65.
Strano Rossi S, Botre F. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review. J Sports Sci. 2011;29(5):471–6.
Peretti-Watel P, Beck F, Legleye S. Beyond the U-curve: the relationship between sport and alcohol, cigarette and cannabis use in adolescents. Addiction. 2002;97(6):707–16.
Brisola-Santos MB, Gil F, Sampaio-Junior B, Marin MCD, de Andrade AG, Richter KP, et al. Prevalence and correlates of cannabis use among athletes—a systematic review. Am J Addict. 2016;(7):518-28.
Harcourt PR, Unglik H, Cook JL. A strategy to reduce illicit drug use is effective in elite Australian football. Br J Sports Med. 2012:bjsports-2012-091329.
Momaya A, Fawal M, Estes R. Performance-enhancing substances in sports: a review of the literature. Sports Med. 2015;45(4):517–31.
Reardon CL, Creado S. Drug abuse in athletes. Substance Abuse and Rehabilitation. 2014;5:95–105.
Halkitis PN, Moeller RW, Siconolfi DE, Jerome RC, Rogers M, Schillinger J. Methamphetamine and poly-substance use among gym-attending men who have sex with men in New York City. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2008;35(1):41–8.
Bolding G, Hart G, Sherr L, Elford J. Use of crystal methamphetamine among gay men in London. Addiction. 2006;101(11):1622–30.
Molero Y, Gripenberg J, Bakshi AS. Effectiveness and implementation of a community-based prevention programme targeting anabolic androgenic steroid use in gyms: study protocol of a quasi-experimental control group study. BMC sports science, medicine and rehabilitation. 2016;8:36.
Swedish Association of Local Authorities and Regions [Statens Kommuner och Landsting]. Division of municipalities 2017 [Kommungruppsindelning 2017]. Stockholm: Sveriges Kommuner och Landsting, ISBN: 978-91-7585-455-7; 2016.
Leifman H, Rehnman C, Sjoblom E, Holgersson S. Anabolic androgenic steroids—use and correlates among gym users—an assessment study using questionnaires and observations at gyms in the Stockholm region. Int J Environ Res Public Health. 2011;8(7):2656–74.
Skärstrand E. Prevention of alcohol and drug problems among adolescents: evaluating a Swedish version of the Strengthening Families Program: Inst för folkhälsovetenskap/Dept of Public Health Sciences. Solna: Karolinska Institutet; 2010.
Strandberg A. Evaluation of a Swedish parental prevention program: youth drunkenness, alcohol-specific parenting and gender differences: Inst för folkhälsovetenskap/Dept of Public Health Sciences. Solna: Karolinska Institutet; 2014.
The Public Health Agency of Sweden [Folhälsomyndigheten]. Drug use in Sweden [Narkotikabruket i Sverige]. Östersund: Folkhälsomyndigheten, ISBN: 978-91-7257-713-8; 2010.
Ramstedt M, Sundin E, Landberg J, Raninen J. Alcohol, narcotics, doping, and tobacco use and its negative consequences in the Swedish population—a study focused on misuse, abuse, and other problems related to alcohol, narcotics, doping, and tobacco [ANDT-bruket och dess negativa konsekvenser i den svenska befolkningen 2013—en studie med fokus på missbruk och beroende samt problem för andra än brukaren relaterat till alkohol, narkotika, doping och tobak]. Stockholm: STAD; 2014. ISBN: 978-91-85997-24-4.
European Monitoring Centre for Drugs and Drug Addiction. European drug report 2016: trends and developments. Luxembourg; 2016.
Degenhardt L, Bucello C, Calabria B, Nelson P, Roberts A, Hall W, et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend. 2011;117(2–3):85–101.
Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (London, England). 2012;379(9810):55–70.
The Public Health Agency of Sweden (Folhälsomyndigheten). The 2013 national report (2012 data) to the EMCDDA by the Reitox National Focal Point Sweden. New development and trends. Östersund: STATENS FOLKHÄLSOINSTITUT A; 2013. p. 2.
Kanayama G, Hudson JI, Pope HG Jr. Illicit anabolic-androgenic steroid use. Horm Behav. 2010;58(1):111–21.
Clarkson PM, Thompson HS. Drugs and Sport. Sports Med. 1997;24(6):366–84.
Huestis MA, Mazzoni I, Rabin O. Cannabis in Sport. Sports Med. 2011;41(11):949–66.
Kanayama G, Pope HG Jr, Hudson JI. “Body image” drugs: a growing psychosomatic problem. Psychother Psychosom. 2001;70(2):61–5.
Andreasson J. Reconceptualising the gender of fitness doping: performing and negotiating masculinity through drug-use practices. Soc Sci. 2015;4(3):546–62.
Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81(1):11–9.
Korhonen T, Kujala UM, Rose RJ, Kaprio J. Physical activity in adolescence as a predictor of alcohol and illicit drug use in early adulthood: a longitudinal population-based twin study. Twin research and human genetics : the official journal of the International Society for Twin Studies. 2009;12(3):261–8.
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383–98.
Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addiction & health. 2013;5(3–4):77.
Alsaeed I, Alabkal JR. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait—a cross-sectional study. Subst Abuse Treat Prev Policy. 2015;10:33.
Skarberg K, Nyberg F, Engstrom I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res. 2009;15(2):99–106.
Arvary D, Pope HG Jr. Anabolic-androgenic steroids as a gateway to opioid dependence. N Engl J Med. 2000;342(20):1532.
Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? The Journal of clinical psychiatry. 2003;64(2):156–60.
Gripenberg-Abdon J, Elgan TH, Wallin E, Shaafati M, Beck O, Andreasson S. Measuring substance use in the club setting: a feasibility study using biochemical markers. Subst Abuse Treat Prev Policy. 2012;7:7.
Nordfjaern T, Bretteville-Jensen AL, Edland-Gryt M, Gripenberg J. Risky substance use among young adults in the nightlife arena: an underused setting for risk-reducing interventions? Scandinavian journal of public health. 2016. [Epub ahead of print].
Bullock S. Alcohol, drugs and student lifestyle: a study of the attitudes, beliefs and use of alcohol and drugs among Swedish university students. Stockholm: SoRAD - Research Report nr 21 ISBN: 91-975134-7; 2004.
Lindsay J. ‘Partying hard’, ‘partying sometimes’ or ‘shopping’: young workers’ socializing patterns and sexual, alcohol and illicit drug risk taking. Critical Public Health. 2003;13(1):1–14.